Dr. Wrangle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-937-6110- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
- Emory University School of MedicineResidency, Internal Medicine, 2005 - 2008
- Tulane University School of MedicineClass of 2005
Certifications & Licensure
- SC State Medical License 2014 - 2025
- MD State Medical License 2008 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Publications & Presentations
PubMed
- 273 citationsALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn Wrangle, Vamsidhar Velcheti, Manish R. Patel, Elizabeth Garrett-Mayer, Elizabeth G. Hill
The Lancet. Oncology. 2018-05-01 - 1522 citationsFirst-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung CancerDavid P. Carbone, Martin Reck, Luis Paz-Ares, Benjamin C. Creelan, Leora Horn
The New England Journal of Medicine. 2017-06-21 - 109 citationsNeutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinomaSaleh Rachidi, Kristin Wallace, John Wrangle, Terry A. Day, Anthony J. Alberg
Head & Neck. 2016-04-01
Press Mentions
- FDA, SC Experts Say COVID Boosters Will Help Some Patients — but Not Everyone Gets One YetAugust 13th, 2021
- COVID-19: The State of the ScienceMay 19th, 2021
- ImmunityBio Announces Positive Phase 2 Results Showing That Anktiva Restores the Activity of Checkpoint Inhibitors in Patients Who Have Relapsed Checkpoint Immunotherapy in Non-Small Cell Lung CancerJanuary 28th, 2021
- Join now to see all
Hospital Affiliations
- MUSC Health University Medical CenterCharleston, South Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: